List of insiders holdings for RespireRx Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner | 2020-10-02 15:47:00 | 171 107,048,385 | 107,048,556 | Form 4 |
AURORA CAPITAL LLC Member of a 10% owner group | 2013-06-19 16:32:17 | 24,200,507 0 | 24,200,507 | Form 13D |
ORIGIN VENTURES II LP Origin Ventures II Management LLC BARRON BRUCE N Miller Steven N. 10% Owner | 2013-06-19 16:35:17 | 24,200,507 0 | 24,200,507 | Form 13G |
samyang optics co. ltd Samyang Value Partners Co. Ltd. 10% Owner | 2013-06-19 16:39:22 | 22,113,831 0 | 22,113,831 | Form 13D |
IllinoisVentures GP LLC ILLINOIS EMERGING TECHNOLOGIES FUND LP 10% Owner | 2012-08-20 16:48:41 | 20,334,546 0 | 20,334,546 | Form 13G |
Jones Timothy L. CEO and President | 2020-10-02 15:51:43 | 8,818,154 0 | 8,818,154 | Form 4 |
MacFarlane Katie Director | 2020-10-02 15:50:56 | 5,000,000 0 | 5,000,000 | Form 4 |
Purcell Richard David Jr. SVP - Research and Development | 2020-08-04 14:25:58 | 5,000,000 0 | 5,000,000 | Form 4 |
Radin Marc M Controller | 2014-04-16 20:14:05 | 4,000,000 0 | 4,000,000 | Form 4 |
STOLL ROGER G PHD Executive Chairman | 2012-08-14 16:05:05 | 3,083,334 0 | 3,083,334 | Form 4 |
AURORA CAPITAL CORP Member of 10% owner group | 2013-04-01 18:01:29 | 0 2,971,792 | 2,971,792 | Form 3 |
T. Morgen Capital LLC Member of 10% owner group | 2013-04-01 17:34:52 | 0 2,971,792 | 2,971,792 | Form 3 |
COLEMAN JAMES H Sr. VP, Business Development | 2012-08-14 16:04:28 | 2,083,334 0 | 2,083,334 | Form 4 |
Dickason David SVP of Pre-Clinical Prod. Dev. | 2020-10-06 15:20:38 | 2,000,000 0 | 2,000,000 | Form 4 |
Carley David W. Director | 2012-08-20 16:12:32 | 1,899,158 0 | 1,899,158 | Form 4 |
MANUSO JAMES S J President and CEO | 2017-12-12 18:49:47 | 1,198,149 0 | 1,198,149 | Form 4 |
Letendre Peter Director | 2012-08-20 16:05:12 | 684,031 0 | 684,031 | Form 4 |
Cohen Kenneth M Member of 10% owner group | 2013-04-01 18:20:30 | 656,755 0 | 656,755 | Form 3 |
Varney Mark A President and CEO | 2009-08-24 19:28:31 | 588,000 0 | 588,000 | Form 4 |
Benedik John F Director | 2012-08-07 16:11:20 | 493,333 0 | 493,333 | Form 4 |
JOHNSON M ROSS Director | 2012-08-07 16:16:07 | 428,333 0 | 428,333 | Form 4 |
DRAKE PETER F Director | 2012-08-07 16:15:11 | 406,667 0 | 406,667 | Form 4 |
CASAMENTO CHARLES J Director | 2012-08-07 16:13:17 | 406,667 0 | 406,667 | Form 4 |
MESSINGER MARIA S Chief Financial Officer | 2009-08-24 19:22:15 | 380,000 0 | 380,000 | Form 4 |
ALLNUTT ROBERT Director | 2012-08-07 16:10:34 | 363,333 0 | 363,333 | Form 4 |
Chizzik Steven Member of 10% owner group | 2013-04-01 18:07:36 | 330,199 0 | 330,199 | Form 3 |
COTMAN CARL W Director | 2012-08-07 16:14:00 | 276,667 0 | 276,667 | Form 4 |
WEINGARTEN ROBERT N EVP & Chief Financial Officer | 2017-01-20 21:10:36 | 216,156 0 | 216,156 | Form 4 |
SAPIRSTEIN JAMES Director | 2017-12-12 19:38:21 | 134,269 0 | 134,269 | Form 4 |
Mansbach Harry H Chief Medical Officer | 2005-12-05 12:28:13 | 100,000 0 | 100,000 | Form 4 |
ROGERS GARY ALLEN Sr VP, Pharmaceutical Research | 2007-02-07 19:33:38 | 0 58,399 | 58,399 | Form 5 |
Tran Pierre V Chief Medical Officer | 2009-08-24 19:24:53 | 50,000 0 | 50,000 | Form 4 |
TOLLEFSON GARY D Director | 2008-02-13 19:14:23 | 30,000 0 | 30,000 | Form 4 |
Lippa Arnold Exec. Chairman & CSO | 2020-10-02 15:47:42 | 100 0 | 100 | Form 4 |
Johnson Steven Andrew VP, Preclinical Development | 2010-02-02 20:46:54 | 0 0 | 0 | Form 5 |
Hwang Moogak Director | 2012-08-09 18:24:37 | 0 0 | 0 | Form 3 |
HYER KATHRYN BURRER Director | 2012-08-14 13:42:18 | 0 0 | 0 | Form 3 |